<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
 <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
 <link rel="stylesheet" type="text/css" href="savehtml.css"/>
 <title>Grk5 ---| Adrb2
 </title>
</head>
<body>
 <div class="props">
  <h1>ProtModification Grk5 ---| Adrb2</h1>
  <table>
   <tbody>
    <tr>
     <th align="left">URN
     </th>
     <td>urn:agi-ProtModification:inout-urn:agi-llid:2869:out-urn:agi-llid:154::unknown
     </td>
    </tr>
    <tr>
     <th align="left">References
     </th>
     <td>7
     </td>
    </tr>
    <tr>
     <th align="left">Connectivity
     </th>
     <td>2
     </td>
    </tr>
    <tr>
     <th align="left">Effect
     </th>
     <td>unknown
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8662852&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/8662852#abs:4
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8662852&amp;dopt=AbstractPlus" target="AGI_EXT_REF">8662852:3
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Here we report the identification of the sites of GRK2- and GRK5-mediated beta2AR phosphorylation.
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8170959&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/8170959#abs:8
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">CellLineName
     </th>
     <td>Sf9
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8170959&amp;dopt=AbstractPlus" target="AGI_EXT_REF">8170959:7
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>While phosphorylation of the beta 2-AR by GRK2, -3, and -5 is similar, the activity of GRK2 and -3 is enhanced by G beta gamma whereas that of GRK5 is not.
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8120045&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/8120045#abs:6
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">CellLineName
     </th>
     <td>Sf9
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8120045&amp;dopt=AbstractPlus" target="AGI_EXT_REF">8120045:5
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Purified GRK5 phosphorylates rhodopsin in a light-dependent manner and beta 2-adrenergic receptor in an agonist-dependent manner and phosphorylates the C-terminal tail regions of both receptor proteins.
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10499588&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/10499588#abs:6
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10499588&amp;dopt=AbstractPlus" target="AGI_EXT_REF">10499588:5
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>A serine residue at position 411 in the tail of the beta2-adrenergic receptor is a substrate for phosphorylation by GRK-5 (for G-protein-coupled-receptor kinase-5) and is required for interaction with EBP50 and for proper recycling of the receptor.
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8144599&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/8144599#abs:5
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8144599&amp;dopt=AbstractPlus" target="AGI_EXT_REF">8144599:4
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Expression and characterization of a mutant GRK5 that does not autophosphorylate (S484A and T485A) reveals that the mutant has a approximately 15-20-fold reduced ability to phosphorylate the beta 2-adrenergic receptor and rhodopsin compared to wild type GRK5.
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=19092051&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/19092051#abs:5
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=19092051&amp;dopt=AbstractPlus" target="AGI_EXT_REF">19092051:4
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>However, tyrosyl phosphorylation of GRK5 was not necessary for GRK5-mediated phosphorylation of the beta(2)-adrenergic receptor, even though beta(2)-adrenergic receptor activation promoted tyrosyl phosphorylation of GRK5 in smooth muscle cells.
     </td>
    </tr>
    <tr>
     <th align="left">Tissue
     </th>
     <td>smooth muscle
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">TextRef
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8288567&amp;dopt=AbstractPlus" target="AGI_EXT_REF">info:pmid/8288567#abs:4
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8288567&amp;dopt=AbstractPlus" target="AGI_EXT_REF">8288567:3
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>GRK5 phosphorylates the beta 2-adrenergic receptor (beta 2AR), m2 muscarinic cholinergic receptor, and rhodopsin in an agonist-dependent manner to maximal stoichiometries of approximately 2.5, 1.5, and 1 mol of phosphate/mol of receptor, respectively, with Km values of approximately 0.5 microM for the beta 2AR, approximately 16 microM for rhodopsin, and approximately 24 microM for ATP.
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
 </div>
</body>
</html>